Skip Navigation
Skip to contents



12 results

Metastasis to the Thigh Skeletal Muscle from an Adenocarcinoma of the Duodenum

Gil HW, Won JH, Lee NS, Lee SC, Kim SE, Kim CK, Lee KT, Park SK, Baick SH, Hong DS, Park HS

  • Cancer Res Treat.
  • 2002 Oct;34(5):394-396.
Skeletal muscle is one of the most unusual metastatic sites for any malignancy. Duodenal cancer is extremely rare, and no cases of skeletal muscle metastasis from duodenal cancer have been...
Interrelation of Cyclin D1, Cyclin E, and p27Kip1 Expression on Tissue Arrays of Breast Cancer

Han SH, Park KM, Bae BN, Ryu SY, Kim KH, Kim HJ, Kim YD, Kim HY

  • Cancer Res Treat.
  • 2002 Oct;34(5):388-393.
PURPOSE: To evaluate the clinical impact of the altered expression of cell cycle regulators in stage I and II breast cancers. MATERIALS AND METHODS: The interaction between cyclin D1/E and p27Kip1...
Salvage Treatment for Advanced Gastric Cancer Using FEP (5-FU, Etoposide, Cisplatin) Combination Chemotherapy

Chung JH, Bae YZ, Kim SH, Moon CH, Chung JY, Kwon HC, Kim JS, Kim HJ

  • Cancer Res Treat.
  • 2002 Oct;34(5):382-387.
PURPOSE: There is no effective treatment for patients with advanced gastric cancer having failed to respond to first line chemotherapy. The aim of this study was to evaluate the therapeutic...
Antitumor Activity of Oxaliplatin, 5-FU and Paclitaxel Given Alone or in Combination with ZD1839 in Human Gastric Carcinoma Cells in vitro

Jang JH, Lee SH, Kang JH, Sun HS, Nishio K, Saijo N, Kuh HJ

  • Cancer Res Treat.
  • 2002 Oct;34(5):372-381.
PURPOSE: Oxaliplatin (LOHP), 5-FU, and paclitaxel (PTX) are considered highly active against advanced gastric carcinomas, and the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, ZD1839 is considered as a...
Results of Curative Radiotherapy Alone in Patients with Uterine Cervical Carcinomas

Nam TK, Nah BS, Ahn SJ, Chung WK, Choi HS, Oh YK

  • Cancer Res Treat.
  • 2002 Oct;34(5):365-371.
PURPOSE: To evaluate the role of curative radiotherapy alone in the treatment of uterine cervical carcinomas, by a retrospective analysis with respects to survival and pelvic control, and to find...
Polymorphisms of p53, p21 and IRF-1 and Cervical Cancer Susceptibility in Korean Women

Lee SJ, Namkoong S, Lee WC, Sul JW, Jee SH, You YK, Lee JE, Park JS

  • Cancer Res Treat.
  • 2002 Oct;34(5):357-364.
PURPOSE: The aim of this study was to identify gene- gene and gene-environmental factor on cervical carcinogenesis in Korean women. MATERIALS AND METHODS: We evaluated 185 women patients who had cervical...
Effect of Vinorelbine, Ifosfamide and Cisplatin Combination Chemotherapy in Stage III-IV Non-Small-Cell Lung Cancer

Kim YC, Lee SY, Cho HJ, Kim JA, Song SH, Kim CH, Kim HK, Ahn MI, You JY, Kim SW, Cho DG, Cho KD, Kang JH

  • Cancer Res Treat.
  • 2002 Oct;34(5):352-356.
PURPOSE: To evaluate the response rates, toxicitiesy, and survival rates, to vinorelbine (Navelbine(R)), cisplatin and ifosfamide combination chemotherapy, of the patients with inoperable NSCLC (stage III and IV), who received...
Preliminary Results of Paclitaxel, Cisplatin and Concurrent High-Dose Radiation Therapy for Locally Advanced Non-Small-Cell Lung Cancer

Lee SW, Choi EK, Oh SJ, Suh CW, Kim SW, Lee JS, Kim DS, Kim WD, Kim WS, Lee SD, Kim JH, Ahn SD, Kim KJ, Noh YJ

  • Cancer Res Treat.
  • 2002 Oct;34(5):345-351.
PURPOSE: To investigate the feasibility, toxicity and response rate, of concurrent chemoradiation therapy with paclitaxel/cisplatin in stage III locally advanced non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Between May 1999...
actate Dehydrogenase (LDH) as a Tumor Marker for Non-small Cell Lung Cancer

Yuh YJ, Kim SR

  • Cancer Res Treat.
  • 2002 Oct;34(5):339-344.
PURPOSE: To determine the prognostic value of pre- treatment serum LDH levels and the LDH isoenzyme pattern for non-small cell lung cancer, and to determine the relationship between the response...
Phase II Study of Topotecan and Etoposide as Second-line Treatment in Chemotherapy-refractory Small-cell Lung Cancer

Kim C, Sohn JH, Kim JH, Kim SK, Kim YS, Chang J, Cho JY

  • Cancer Res Treat.
  • 2002 Oct;34(5):334-338.
PURPOSE: Refractory small-cell lung cancer (SCLC) has a poor prognosis, and current salvage chemotherapy for refractory SCLC, such as CAV (cyclophosphamide, adriamycin, vincristine) or topotecan, has an unsatisfactory outcome, with...
The Effect of Intensified Induction Using Vanderbilt Regimen in Patients with an Intermediate Grade Non-Hodgkin's Lymphoma Having 2 or 3 Adverse Factors on the Age-adjusted International Prognostic Index

Kweon YJ, Choi SJ, Ryoo BY, Park YH, Kim BS, Kim DH, Kim SI, Kim SH, Suh YA, Son HB, Choi KS, Lee SS, Kang YK

  • Cancer Res Treat.
  • 2002 Oct;34(5):326-333.
PURPOSE: The purpose of our study was to evaluate the outcome of intensified induction therapy using the Vanderbilt regimen in patients with a poor prognosis non-Hodgkin's lymphoma (NHL). MATERIALS AND METHODS:...
Survival of Korean Cancer Patients Diagnosed in 1995

Bae JM, Won YJ, Jung KW, Suh KA, Yun YH, Shin MH, Ahn YO, Lee DH, Shin HR, Ahn DH, Oh DK, Park JG, 134 KCCR-affiliated Hospitals

  • Cancer Res Treat.
  • 2002 Oct;34(5):319-325.
PURPOSE: To produce the nationwide 5-year survival rates of Korean cancer patients by primary cancer site. MATERIALS AND METHODS: The study subjects were cancer patients diagnosed in 1995, as documented by...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: